Spironolactone Plus Metformin in Polycystic Ovary Syndrome
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The investigators examined whether a combined therapy with low-dose spironolactone plus
metformin is more effective than metformin alone in 52 overweight/obese Polycystic Ovary
Syndrome (PCOS) patients.